StockStory.org on MSN
PacBio (NASDAQ:PACB) misses Q1 CY2026 sales expectations
Genomics company Pacific Biosciences of California (NASDAQ:PACB) in Q1 CY2026, with sales flat year on year at $37.18 million ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Pacific Biosciences of California, Inc. (NASDAQ:PACB) is among the 12 Best Genomics Stocks to Invest In. On December 15, TheFly published that Luke Sergott, a Barclays analyst, lifted the price ...
Pacific Biosciences of California Inc. (NASDAQ:PACB) is one of the 8 Best Life Sciences Penny Stocks to Buy. On March 18, Pacific Biosciences of California Inc. (NASDAQ:PACB) revealed that Basecamp ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results